Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Adrenomedullin acutely decreases myocardial stiffness - An endocardial endothelium mediated-effect.
Publication

Publications

Adrenomedullin acutely decreases myocardial stiffness - An endocardial endothelium mediated-effect.

Title
Adrenomedullin acutely decreases myocardial stiffness - An endocardial endothelium mediated-effect.
Type
Summary of Presentation in an International Conference
Year
2007
Authors
Fontes-Sousa AP
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pires AL
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications Without AUTHENTICUS Without ORCID
Santos Carneiro C
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Leite-Moreira AF
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Conference proceedings International
Initial page: II-190
80th Scientific Sessions of the American Heart Association
Orlando, FL, EUA, 04 a 07 de Novembro de 2007
Scientific classification
FOS: Medical and Health sciences > Other medical sciences
Other information
Resumo (PT): Background: Adrenomedullin (AM) is a potent, long-lasting vasoactive peptide originally isolated from human pheochromocytoma. However, the mRNA is expressed in a variety of tissues, including the cardiovascular system. AM has hypotensive, diuretic and natriuretic properties but its role in the development of cardiac pathologies is less clear, considering that it produces disparate biological effects in the cardiovascular system. In the current study, we investigated the, yet unknown, acute effects of AM on the diastolic properties of the myocardium. Methods: Effects of increasing concentrations of AM (10–10 to 10–6M) were evaluated in isolated right papillary muscles from male New Zealand White rabbits (Krebs-Ringer: 1,8mM CaCl2, 35°C) in the presence of intact endocardial endothelium (EE) (n=10) and damaged EE (n=9). Reported parameters include: active tension (AT; mN/mm2), passive tension (PT; mN/mm2) and muscle length (L; L/Lmax). Only significant results (means±SEM, p<0.05) are given, expressed as % change from baseline. Results: In papillary muscles with intact EE, AM induced a significant concentration-dependent negative inotropic effect, with the highest concentration decreasing the AT by 17.8±5.4%. It also promoted a concentration-dependent increase in resting muscle length (increased diastolic distensibility) up to 1.009± 0,003 L/Lmax at the highest concentration. Correcting muscle length to its initial value resulted in a 25.0±5.9% decrease of PT, indicating decreased muscle stiffness. The effects of AM on diastolic distensibility were abolished after damaging EE. Conclusion: The present study showed that AM significantly decreased PT, indicating a decrease in myocardial stiffness, an effect that is dependent of the EE. This effect is a potentially powerful physiologic mechanism, as it may allow the heart to reach the same diastolic volume with up to 25% lower filling pressures. Furthermore, as the plasma AM levels are increased in cardiovascular diseases such as heart failure, this is a novel finding with potential pathophysiologic and therapeutic implications in this syndrome, which deserves further investigation.
Language: English
Type (Professor's evaluation): Scientific
Notes: 80th Scientific Sessions of the American Heart Association, published in journal, Circulation 2007; 116: II-190.
Documents
We could not find any documents associated to the publication.
Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-15 at 16:05:45 | Privacy Policy | Personal Data Protection Policy | Whistleblowing